CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bustelo, X. R.
Right arrow Articles by Barbacid, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bustelo, X. R.
Right arrow Articles by Barbacid, M.

Cell Growth & Differentiation, Vol 4, Issue 4 297-308, Copyright © 1993 by American Association of Cancer Research


ARTICLES

Developmental expression of the vav protooncogene

XR Bustelo, SD Rubin, KL Suen, D Carrasco and M Barbacid
Department of Molecular Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.

We have examined the expression of the vav protooncogene during mouse embryogenesis using RNase protection assays, in situ hybridization, and immunocytochemical analysis. vav gene transcripts were first detected in E11.5 embryos in the blood-forming islands and megakaryocytes of the fetal liver. During diversification of hematopoietic activity in the embryo, vav gene expression became down-regulated in the liver and activated in thymus and spleen. In newborn animals, vav expression was also confined to hematopoietic tissues, with the exception of the ameloblastic cell layer at the latest stages of tooth morphogenesis. In the adult, vav transcripts were found in spleen, thymus, lymph nodes, and bone marrow, but not in liver. In spleen, vav transcripts were concentrated in the white pulp areas, whereas in the red pulp, the vav transcripts appeared to be primarily localized in the megakaryocytes. In thymus, vav expression was found to be more abundant in the cortical areas than in the medulla. In agreement with these observations, purified thymic lymphocytes showed heterogeneous immunoreactivity against the Vav protein, whereas splenic lymphocytes and bone marrow-derived cells displayed rather uniform levels of expression. These observations suggest that the vav protooncogene plays an important role in the signal transduction pathways that regulate the development and maintenance of the hematopoietic system.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Ruiz, A. Castro-Castro, and X. R. Bustelo
CD147 Inhibits the Nuclear Factor of Activated T-cells by Impairing Vav1 and Rac1 Downstream Signaling
J. Biol. Chem., February 29, 2008; 283(9): 5554 - 5566.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
K. Inabe, M. Ishiai, A. M. Scharenberg, N. Freshney, J. Downward, and T. Kurosaki
Vav3 Modulates B Cell Receptor Responses by Regulating Phosphoinositide 3-Kinase Activation
J. Exp. Med., January 14, 2002; 195(2): 189 - 200.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C V Clevenger and J B Kline
Prolactin receptor signal transduction
Lupus, October 1, 2001; 10(10): 706 - 718.
[Abstract] [PDF]


Home page
J. Cell Biol.Home page
P. A. Marignani and C. L. Carpenter
Vav2 is required for cell spreading
J. Cell Biol., July 9, 2001; 154(1): 177 - 186.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. López-Lago, H. Lee, C. Cruz, N. Movilla, and X. R. Bustelo
Tyrosine Phosphorylation Mediates Both Activation and Downmodulation of the Biological Activity of Vav
Mol. Cell. Biol., March 1, 2000; 20(5): 1678 - 1691.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Ogilvy, D. Metcalf, C. G. Print, M. L. Bath, A. W. Harris, and J. M. Adams
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival
PNAS, December 21, 1999; 96(26): 14943 - 14948.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Ogilvy, D. Metcalf, L. Gibson, M. L. Bath, A. W. Harris, and J. M. Adams
Promoter Elements of vav Drive Transgene Expression In Vivo Throughout the Hematopoietic Compartment
Blood, September 15, 1999; 94(6): 1855 - 1863.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. S. Song, H. Haleem-Smith, R. Arudchandran, J. Gomez, P. M. Scott, J. F. Mill, T.-H. Tan, and J. Rivera
Tyrosine Phosphorylation of Vav Stimulates IL-6 Production in Mast Cells by a Rac/c-Jun N-Terminal Kinase-Dependent Pathway
J. Immunol., July 15, 1999; 163(2): 802 - 810.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. I. Gringhuis, L. F. M. H. de Leij, P. J. Coffer, and E. Vellenga
Signaling through CD5 Activates a Pathway Involving Phosphatidylinositol 3-Kinase, Vav, and Rac1 in Human Mature T Lymphocytes
Mol. Cell. Biol., March 1, 1998; 18(3): 1725 - 1735.
[Abstract] [Full Text]


Home page
BloodHome page
S. Ogilvy, A. G. Elefanty, J. Visvader, M. L. Bath, A. W. Harris, and J. M. Adams
Transcriptional Regulation of vav, a Gene Expressed Throughout the Hematopoietic Compartment
Blood, January 15, 1998; 91(2): 419 - 430.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
N Bonnefoy-Berard, A Munshi, I Yron, S Wu, T. Collins, M Deckert, T Shalom- Barak, L Giampa, E Herbert, J Hernandez, et al.
Vav: function and regulation in hematopoietic cell signaling
Stem Cells, May 1, 1996; 14(3): 250 - 268.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.